key: cord-0708232-yrf48dqy
authors: Sarwar Shah, Syed Ghulam; Awais, Sayema; Hussain Shah, Sayed Fida
title: Commentary on “Setting up a COVID-19 care facility at a prison: An experience from Pakistan”
date: 2020-09-10
journal: Ann Med Surg (Lond)
DOI: 10.1016/j.amsu.2020.09.018
sha: 603134ba46a61ec273e26da71b18ab03089e75b8
doc_id: 708232
cord_uid: yrf48dqy

nan

Commentary on " Commentary on " Commentary on " Commentary on "Setting up a COVID Setting up a COVID Setting up a COVID Setting up a COVID----19 care facility at a prison: An experience 19 care facility at a prison: An experience 19 care facility at a prison: An experience 19 care facility at a prison: An experience from Pakistan from Pakistan from Pakistan from Pakistan" " " " Ayyaz et al [1] have reported the establishment of a COVID-19 care facility for inmates in a jail . This study is a unique study amongst numerous studies that have been published so far on the COVID-19 pandemic because it is about the COVID-19 care of prisoners who are one of the vulnerable groups to COVID-19 because they live in incarcerated settings [2] . Another unique characteristic of the study is that it has been undertaken in a higher-risk setting i.e. prison in a resource constrained country i.e. Pakistan -a lower middle income country (LMIC).

Ayyaz et al have reported various important actions that were implemented in setting up the COVID-19 facility in a prison such as temporary stoppage of taking in of new prisoners, testing of the inmates and staff for COVID-19, caring for prisoners who were COVID-19 positive and taking preventative measures such as providing sanitizers for handwashing and contact tracing for controlling the spread of coronavirus infection amongst prisoners, staff and visitors to the prison and providing care to the prisoners who had COVID-19 [1] . Besides successful outcomes such as a limited morbidity and no mortality due to COVID-19 in the prison, Ayyaz et al have stressed upon some key issues such as the involvement of all key stakeholders, the need for proper preparation and coordination, and encountering different challenges and problems in this work [1] . However, they have neither described the problems and challenges nor discussed how these were overcome. Describing these important issues would have been helpful in understanding the nature of challenges and taking appropriate actions whilst planning for and setting up of care facilities elsewhere in response to COVID-19.

The COVID-19 pandemic has resulted in little more than 23 million confirmed cases and about 0.8 million deaths globally, as of 24th August 2020 [3]. The COVID-19 has directly or indirectly affected almost every individual albeit at a varying level. However, some people are more vulnerable to COVID-19 than others such as people in care homes [4] and prisoners in jails [5] . These places are often overcrowded, more likely hotbeds for the spread of communicable diseases and mostly have limited healthcare resources and facilities [6, 7] .

It is therefore imperative to prioritise the most vulnerable people in COVID-19 testing and healthcare provision during the COVID-19 pandemic. Besides prisoners, there are many other vulnerable people such as patients and elderly in care homes, people in shelter houses, orphanages and similar other dwellings, mental health patients in psychiatric centres and hospitals, and refugees and displaced people in camps and detention centres. These disadvantaged and vulnerable people must need special attention and priority in testing for COVID-19 and providing them with necessary healthcare onsite.

Not commissioned, Editor reviewed.

Authors declare no conflict of interest.

Even where consent has been given, identifying details should be omitted if they are not essential. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note.

Not applicable because this is commentary on an article published in the Ann Med Surg.

In accordance with the Declaration of Helsinki 2013, all research involving human participants has to be registered in a publicly accessible database. Please enter the name of the registry and the unique identifying number (UIN) of your study.

Setting up a COVID-19 care facility at a prison: An experience from Pakistan

World Health Organization, Preparedness, prevention and control of COVID-19 in prisons and other places of detention. Interim guidance, WHO Regional Office for Europe

Do all care home residents face an equal risk of dying from COVID-19?, The Health Foundation

Prisons are "in no way equipped" to deal with COVID-19

Prisons and Health, WHO Regional Office for Europe

They're Death Pits': Virus Claims at Least 7,000 Lives in U.S. Nursing Homes

Unique Identifying number or registration ID: N/A 3. Hyperlink to your specific registration (must be publicly accessible and will be checked): N/A Author contribution Please specify the contribution of each author to the paper, e.g. study design, data collections, data analysis, writing. Others, who have contributed in other ways should be listed as contributors. Study conception, planning and design; All authors

The research work by S.G.S. Shah is supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre. The views expressed in this commentary are those of the authors and not of their organisations.

Please state any sources of funding for your research All sources of funding should be declared as an acknowledgement at the end of the text. Authors should declare the role of study sponsors, if any, in the collection, analysis and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication. If the study sponsors had no such involvement, the authors should so state.

Research studies involving patients require ethical approval. Please state whether approval has been given, name the relevant ethics committee and the state the reference number for their judgement.Not applicable because this is commentary on an article published in the Ann Med Surg.

Studies on patients or volunteers require ethics committee approval and fully informed written consent which should be documented in the paper.Authors must obtain written and signed consent to publish a case report from the patient (or, where applicable, the patient's guardian or next of kin) prior to submission. We ask Authors to confirm as part of the submission process that such consent has been obtained, and the manuscript must include a statement to this effect in a consent section at the end of the manuscript, as follows: "Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal on request".Patients have a right to privacy. Patients' and volunteers' names, initials, or hospital numbers should not be used. Images of patients or volunteers should not be used unless the information is essential for scientific purposes and explicit permission has been given as part of the consent. If such consent is made subject to any conditions, the Editor in Chief must be made aware of all such conditions.